Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Prostatic Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Temozolomide 5Radiotherapy 4Carmustine 3Surgical Procedures, Operative 2Hyperbaric Oxygenation 2Ethanol 2Carboplatin 2pembrolizumab 1lonafarnib 1ipatasertib 1interleukin-4-Pseudomonas exotoxin 1dactolisib 1Verteporfin 1Tamoxifen 1Procarbazine 1Phosphorus-32 1Pemetrexed 1Neoadjuvant Therapy 1Lomustine 1Erlotinib Hydrochloride 1Dihematoporphyrin Ether 1Chlorotoxin 1Chemotherapy, Adjuvant 1Brachytherapy 1Arsenic Trioxide 17-tert-butyldimethylsilyl-10-hydroxycamptothecin 12-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gliosarcoma × Phosphorus-32 × Clear all
NCT00004129 2013-09-17

Phosphorus 32 in Treating Patients With Glioblastoma Multiforme

National Cancer Institute (NCI)

Phase 1 Unknown
12 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡